期刊文献+

Rb基因信号通路相关因子的定量表达和对口咽鳞癌预后的价值

Quantitative expression and the predictive value of the components of the retinoblastoma pathway in oropharyngeal squamous cell cancer
下载PDF
导出
摘要 目的:明确视网膜母细胞瘤基因信号通路的调节因子与口咽鳞癌的临床进展和预后的关系。方法:对一个95例口咽鳞癌的组织微阵列分别进行了Rb信号通路的相关因子,包括pRb、p16、CyclinD1的免疫荧光组化研究和一种新型的蛋白自动定量分析(AQUA)评估。结果:pRb、p16、CyclinD1的蛋白水平与局部复发率、无瘤生存率和总体生存率密切相关。在多变量风险回归分析中,无论5年局部复发率、无瘤生存率,还是总体生存率,高细胞核表达的Rb基因蛋白和Cyclin D1均被证实是有预后价值的生物因子。结论:视网膜母细胞瘤基因通路在口咽癌的发展演变中起到了重要的作用。该传导通路的相关因子有可能成为治疗口咽癌的靶标记物。 Objective: To determine the association between the components of Rb pathway and clinical outcome and prognosis of oropharyngeal carcinoma. Methods: Fluorescent immunohistochemistry for pRb, p16 and cyclin D1 was carried out on a tissue microarray of 95 oropharyngeal cancer cases with long-term patient follow-up data. For evaluation of protein expression, an automated in-situ quantitative measurement of protein analysis (AQUA) was used. Results: Protein levels of pRb and cyclin D1 were significantly associated with local recurrence, disease-free survival and overall survival. In multivariate Cox regression, high nuclear cyclin D1 and high nuclear Rb expression were proved to be independent predictor for local recurrence, disease-free survival and overall survival at 5 years. Conclusion: Our results indicate that the Rb pathway plays a vitally important role for the clinical outcome in oropharyngeal squamous cell carcinoma. Thus, the components of Rb pathway may be potential targets for molecular intervention in patients with oropharyngeal squamous cell carcinoma.
出处 《山东大学耳鼻喉眼学报》 CAS 2006年第5期391-396,共6页 Journal of Otolaryngology and Ophthalmology of Shandong University
关键词 头颈肿瘤 细胞周期 定量分析 蛋白质组学 Head and neck neoplasms Cell cycle Quantitative analysis Proteomics
  • 相关文献

参考文献23

  • 1Al-Sarraf M. Treatment of locally advanced head and neck cancer: historical and critical review[J]. 2002, Cancer Control, 9: 387-399.
  • 2Sidransky D. Molecular genetics of head and neck cancer[J]. Curt Opin Oncol, 1995, 7:229-233.
  • 3Kamb A, Gruis NA, Weaver-Feldhaus J, et al. A cell cycle regulator potentially involved in genesis of many tumor types[J]. Science, 1994,264:436-440.
  • 4Kim DH, Nelson HH, Wiencke JK, et al. p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer [J]. Cancer Res, 2001, 61:3419-3424.
  • 5Yanagawa N, Tamura G, Oizumi H, et al. Frequent epigenetic silencing of the p16 gene in non-small cell lung cancers of tobacco smokers[J]. Jpn J Cancer Res, 2002, 93: 1107-1113.
  • 6Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4[J]. Nature, 1993, 366:704-707.
  • 7Berenson JR, Yang J, Mickel RA. Frequent amplification of the bcl-1 locus in head and neck squamous cell carcinomas[J]. Oncogene, 1989, 4:1111-1116 .
  • 8Callender T, el-Naggar AK, Lee MS, et al. PRAD-1 (CC-ND1 )/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma[J]. Cancer, 1994, 74: 152-158.
  • 9Jares P, Fernandez PL, Campo E, et al. P.RAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas [J]. Cancer Res, 1994, 54:4813-4817.
  • 10Coleman KG, Wautlet BS, Morrissey D, et al. Identification of CDK4 sequences involved in cyclin D1 and p16 binding[J]. J Biol Chem, 1997, 272:18869-18874.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部